Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intermittent Theta Burst Stimulation (iTBS) for Alleviating Symptoms of Schizophrenia Patients

NCT03868358 is registered in ClinicalTrials.gov with WANG KAI as lead sponsor.

NCT NCT03868358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03868358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intermittent Theta Burst Stimulation (iTBS) for Alleviating Symptoms of Schizophrenia Patients
Lead sponsor
WANG KAI
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2017
Completion date
March 30, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional magnetic resonance imaging, schizophrenia, transcranial magnetic stimulation